Table 3.
T | RN | L | cases | T | L | cases | T | RN | cases | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HGF expression between primary tumors and corresponding metastases | |||||||||||
N | N | N | 3 | N | N | 7 | N | N | 11 | ||
N | P | N | 3 | N | P | 2 | N | P | 7 | ||
P | P | N | 1 | P | N | 3 | P | N | 0 | ||
P | P | P | 14 | P | P | 18 | P | P | 24 | ||
Concordance: 17cases | 17/21 | 25 cases | 25/30 | 35 cases | 35/42 | ||||||
Rate: (both N and P) | 81% | 83% | 83% | ||||||||
Discordance: 4 cases | 4/21 | 5 cases | 5/30 | 7cases | 7/42 | ||||||
Rate (discordance) | 19% | 17% | 17% | ||||||||
Friedman Test | total | McNemar | total | McNemar | total | ||||||
P=0.039 | 21 cases | P=1.000 | 30cases | P=0.016 | 42 cases | ||||||
Met expression (N and P) between primary tumors and matched metastases | |||||||||||
N | N | N | 0 | N | N | 1 | N | N | 1 | ||
P | P | P | 16 | N | P | 2 | N | P | 4 | ||
P | P | N | 2 | P | N | 4 | P | N | 1 | ||
N | P | P | 1 | P | P | 23 | P | P | 36 | ||
N | N | P | 1 | ||||||||
P | N | P | 1 | ||||||||
Concordance: 16 cases | 16/21 | 24 cases | 24/30 | 37 cases | 37/42 | ||||||
Rate: (both N and P) | 76% | 80% | 88% | ||||||||
Discordance: 5 cases | 5/21 | 6 cases | 6/30 | 5 cases | 5/42 | ||||||
Rate (discordance) | 24% | 20% | 12% | ||||||||
Friedman Test | 21 cases | McNemar | 30cases | McNemar | 42 cases | ||||||
P=1.000 | P=1.000 | P=0.375 | |||||||||
T: Primary tumor; RN: Regional lymph node metastasis; L: Synchronous liver metastasis; N: negative, P: positive.